

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 7.58171731 |
| 2 | embryonic process involved in female pregnancy (GO:0060136) | 6.87067183 |
| 3 | regulation of integrin activation (GO:0033623) | 5.65057082 |
| 4 | phospholipid scrambling (GO:0017121) | 5.38692602 |
| 5 | GDP-mannose metabolic process (GO:0019673) | 5.34867826 |
| 6 | proline metabolic process (GO:0006560) | 5.28168928 |
| 7 | behavioral response to nicotine (GO:0035095) | 5.24868494 |
| 8 | intestinal epithelial cell development (GO:0060576) | 5.20884466 |
| 9 | establishment of apical/basal cell polarity (GO:0035089) | 5.17969461 |
| 10 | protein retention in ER lumen (GO:0006621) | 4.84761018 |
| 11 | positive regulation of protein homooligomerization (GO:0032464) | 4.71493417 |
| 12 | transcription from mitochondrial promoter (GO:0006390) | 4.70332091 |
| 13 | replication fork processing (GO:0031297) | 4.64053750 |
| 14 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.62840175 |
| 15 | DNA deamination (GO:0045006) | 4.57511240 |
| 16 | oxidative demethylation (GO:0070989) | 4.46898736 |
| 17 | establishment of monopolar cell polarity (GO:0061162) | 4.33130561 |
| 18 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 4.33130561 |
| 19 | definitive hemopoiesis (GO:0060216) | 4.17057428 |
| 20 | regulation of protein homooligomerization (GO:0032462) | 4.04679999 |
| 21 | fucose catabolic process (GO:0019317) | 4.03780726 |
| 22 | L-fucose metabolic process (GO:0042354) | 4.03780726 |
| 23 | L-fucose catabolic process (GO:0042355) | 4.03780726 |
| 24 | Golgi transport vesicle coating (GO:0048200) | 4.00689394 |
| 25 | COPI coating of Golgi vesicle (GO:0048205) | 4.00689394 |
| 26 | cellular ketone body metabolic process (GO:0046950) | 3.93532458 |
| 27 | hematopoietic stem cell proliferation (GO:0071425) | 3.89126971 |
| 28 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.85731499 |
| 29 | positive regulation of lamellipodium assembly (GO:0010592) | 3.82084162 |
| 30 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.73130372 |
| 31 | negative regulation of stress fiber assembly (GO:0051497) | 3.71227285 |
| 32 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.70917084 |
| 33 | positive regulation of lamellipodium organization (GO:1902745) | 3.68186289 |
| 34 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.67677771 |
| 35 | indolalkylamine metabolic process (GO:0006586) | 3.59300902 |
| 36 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 3.57605905 |
| 37 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.57085543 |
| 38 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.55009985 |
| 39 | indole-containing compound catabolic process (GO:0042436) | 3.54334946 |
| 40 | indolalkylamine catabolic process (GO:0046218) | 3.54334946 |
| 41 | tryptophan catabolic process (GO:0006569) | 3.54334946 |
| 42 | ketone body metabolic process (GO:1902224) | 3.47950279 |
| 43 | cellular response to zinc ion (GO:0071294) | 3.46793582 |
| 44 | kynurenine metabolic process (GO:0070189) | 3.46286644 |
| 45 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.46279810 |
| 46 | nucleotide-sugar metabolic process (GO:0009225) | 3.42075143 |
| 47 | positive regulation of respiratory burst (GO:0060267) | 3.38695982 |
| 48 | fucose metabolic process (GO:0006004) | 3.34409361 |
| 49 | regulation of sister chromatid cohesion (GO:0007063) | 3.34391762 |
| 50 | N-glycan processing (GO:0006491) | 3.33591289 |
| 51 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.28379688 |
| 52 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.27350518 |
| 53 | tryptophan metabolic process (GO:0006568) | 3.24226280 |
| 54 | embryonic placenta development (GO:0001892) | 3.22063386 |
| 55 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.18922461 |
| 56 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.18922461 |
| 57 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.18251004 |
| 58 | epithelial cilium movement (GO:0003351) | 3.16942448 |
| 59 | primary amino compound metabolic process (GO:1901160) | 3.16686132 |
| 60 | regulation of respiratory burst (GO:0060263) | 3.16138875 |
| 61 | axoneme assembly (GO:0035082) | 3.15419185 |
| 62 | response to interferon-beta (GO:0035456) | 3.14776251 |
| 63 | regulation of memory T cell differentiation (GO:0043380) | 3.14690162 |
| 64 | detection of light stimulus involved in visual perception (GO:0050908) | 3.14281440 |
| 65 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.14281440 |
| 66 | fucosylation (GO:0036065) | 3.12399253 |
| 67 | sulfate transmembrane transport (GO:1902358) | 3.10918153 |
| 68 | cornea development in camera-type eye (GO:0061303) | 3.10066016 |
| 69 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.09717292 |
| 70 | mitochondrial DNA metabolic process (GO:0032042) | 3.09146393 |
| 71 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.07694181 |
| 72 | peptide catabolic process (GO:0043171) | 3.04857051 |
| 73 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.04521589 |
| 74 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.03688952 |
| 75 | adaptation of signaling pathway (GO:0023058) | 3.01602248 |
| 76 | galactose catabolic process (GO:0019388) | 2.99282621 |
| 77 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.99031159 |
| 78 | serotonin metabolic process (GO:0042428) | 2.97588390 |
| 79 | gamma-aminobutyric acid transport (GO:0015812) | 2.96636828 |
| 80 | trophectodermal cell differentiation (GO:0001829) | 2.95062238 |
| 81 | indole-containing compound metabolic process (GO:0042430) | 2.94955210 |
| 82 | muscle organ morphogenesis (GO:0048644) | 2.92711547 |
| 83 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.90408610 |
| 84 | membrane invagination (GO:0010324) | 2.90303669 |
| 85 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.90169018 |
| 86 | mitotic cell cycle arrest (GO:0071850) | 2.88046849 |
| 87 | maturation of 5.8S rRNA (GO:0000460) | 2.86978677 |
| 88 | mitochondrial calcium ion transport (GO:0006851) | 2.86533573 |
| 89 | opioid receptor signaling pathway (GO:0038003) | 2.86507319 |
| 90 | platelet dense granule organization (GO:0060155) | 2.84969930 |
| 91 | sulfation (GO:0051923) | 2.84815846 |
| 92 | hepatocyte apoptotic process (GO:0097284) | 2.83335810 |
| 93 | nonmotile primary cilium assembly (GO:0035058) | 2.81026145 |
| 94 | kidney morphogenesis (GO:0060993) | 2.80604232 |
| 95 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.80138092 |
| 96 | positive regulation of Notch signaling pathway (GO:0045747) | 2.79428554 |
| 97 | signal complex assembly (GO:0007172) | 2.79300660 |
| 98 | protein targeting to vacuole (GO:0006623) | 2.79250876 |
| 99 | protein targeting to lysosome (GO:0006622) | 2.79250876 |
| 100 | establishment of protein localization to vacuole (GO:0072666) | 2.79250876 |
| 101 | regulation of lamellipodium assembly (GO:0010591) | 2.79122886 |
| 102 | cilium movement (GO:0003341) | 2.77467314 |
| 103 | negative regulation of viral release from host cell (GO:1902187) | 2.77119649 |
| 104 | negative regulation of mast cell activation (GO:0033004) | 2.76132139 |
| 105 | viral mRNA export from host cell nucleus (GO:0046784) | 2.75914953 |
| 106 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.75472935 |
| 107 | myoblast migration (GO:0051451) | 2.72801523 |
| 108 | interferon-gamma secretion (GO:0072643) | 2.72096027 |
| 109 | cellular response to antibiotic (GO:0071236) | 2.71097439 |
| 110 | regulation of RIG-I signaling pathway (GO:0039535) | 2.70746598 |
| 111 | negative regulation of protein oligomerization (GO:0032460) | 2.69297019 |
| 112 | glandular epithelial cell development (GO:0002068) | 2.67727743 |
| 113 | cellular response to toxic substance (GO:0097237) | 2.67439132 |
| 114 | regulation of lamellipodium organization (GO:1902743) | 2.65184458 |
| 115 | face development (GO:0060324) | 2.64285852 |
| 116 | cytidine deamination (GO:0009972) | 2.63809288 |
| 117 | cytidine metabolic process (GO:0046087) | 2.63809288 |
| 118 | cytidine catabolic process (GO:0006216) | 2.63809288 |
| 119 | sulfur amino acid catabolic process (GO:0000098) | 2.63054610 |
| 120 | megakaryocyte development (GO:0035855) | 2.62799500 |
| 121 | negative regulation of telomere maintenance (GO:0032205) | 2.61354299 |
| 122 | piRNA metabolic process (GO:0034587) | 2.61349573 |
| 123 | macroautophagy (GO:0016236) | 2.61308177 |
| 124 | neuronal action potential (GO:0019228) | 2.60932726 |
| 125 | hypotonic response (GO:0006971) | 2.60105422 |
| 126 | ubiquinone biosynthetic process (GO:0006744) | 2.59505032 |
| 127 | NAD biosynthetic process (GO:0009435) | 2.59112823 |
| 128 | glycerol ether metabolic process (GO:0006662) | 2.58950409 |
| 129 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.58614574 |
| 130 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.58614574 |
| 131 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.58405132 |
| 132 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.57550609 |
| 133 | photoreceptor cell maintenance (GO:0045494) | 2.55934755 |
| 134 | respiratory chain complex IV assembly (GO:0008535) | 2.55801635 |
| 135 | basic amino acid transport (GO:0015802) | 2.55517880 |
| 136 | signal peptide processing (GO:0006465) | 2.55441252 |
| 137 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.55072248 |
| 138 | regulation of action potential (GO:0098900) | 2.54716484 |
| 139 | transcytosis (GO:0045056) | 2.53800735 |
| 140 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 2.53103308 |
| 141 | rRNA catabolic process (GO:0016075) | 2.53044478 |
| 142 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.52342628 |
| 143 | protein polyglutamylation (GO:0018095) | 2.51851147 |
| 144 | thyroid hormone metabolic process (GO:0042403) | 2.51653347 |
| 145 | ubiquinone metabolic process (GO:0006743) | 2.51306151 |
| 146 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.50290080 |
| 147 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.50011300 |
| 148 | alkaloid metabolic process (GO:0009820) | 2.49553599 |
| 149 | positive regulation of defense response to virus by host (GO:0002230) | 2.49283449 |
| 150 | neural tube formation (GO:0001841) | 2.48831292 |
| 151 | regulation of cilium movement (GO:0003352) | 2.48768050 |
| 152 | regulation of keratinocyte differentiation (GO:0045616) | 2.47712295 |
| 153 | cilium morphogenesis (GO:0060271) | 2.47672374 |
| 154 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.47352019 |
| 155 | toxin transport (GO:1901998) | 2.47325099 |
| 156 | endosome to melanosome transport (GO:0035646) | 2.46514010 |
| 157 | endosome to pigment granule transport (GO:0043485) | 2.46514010 |
| 158 | mitotic G1/S transition checkpoint (GO:0044819) | 2.46455365 |
| 159 | negative regulation of cell cycle arrest (GO:0071157) | 2.45857703 |
| 160 | multicellular organism reproduction (GO:0032504) | 2.45374192 |
| 161 | response to pheromone (GO:0019236) | 2.43575220 |
| 162 | segment specification (GO:0007379) | 2.43555696 |
| 163 | reflex (GO:0060004) | 2.42984950 |
| 164 | polarized epithelial cell differentiation (GO:0030859) | 2.42797721 |
| 165 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.42610858 |
| 166 | embryonic eye morphogenesis (GO:0048048) | 2.42325324 |
| 167 | regulation of mitochondrial depolarization (GO:0051900) | 2.41838027 |
| 168 | negative regulation of interleukin-1 production (GO:0032692) | 2.40649742 |
| 169 | nephron tubule morphogenesis (GO:0072078) | 2.39251540 |
| 170 | nephron epithelium morphogenesis (GO:0072088) | 2.39251540 |
| 171 | GPI anchor metabolic process (GO:0006505) | 2.38818531 |
| 172 | axonemal dynein complex assembly (GO:0070286) | 2.38028586 |
| 173 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.34779924 |
| 174 | neurotransmitter metabolic process (GO:0042133) | 2.33828273 |
| 175 | parturition (GO:0007567) | 2.32812272 |
| 176 | cilium organization (GO:0044782) | 2.30679811 |
| 177 | auditory receptor cell stereocilium organization (GO:0060088) | 2.30229699 |
| 178 | exogenous drug catabolic process (GO:0042738) | 2.30187464 |
| 179 | cytochrome complex assembly (GO:0017004) | 2.29282886 |
| 180 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.29168460 |
| 181 | regulation of mesoderm development (GO:2000380) | 2.28846666 |
| 182 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.28334023 |
| 183 | synaptic transmission, cholinergic (GO:0007271) | 2.27830153 |
| 184 | regulation of hippo signaling (GO:0035330) | 2.26871109 |
| 185 | cellular biogenic amine catabolic process (GO:0042402) | 2.26811710 |
| 186 | amine catabolic process (GO:0009310) | 2.26811710 |
| 187 | drug catabolic process (GO:0042737) | 2.24538225 |
| 188 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.24516577 |
| 189 | retinal cone cell development (GO:0046549) | 2.23484422 |
| 190 | quinone biosynthetic process (GO:1901663) | 2.23461049 |
| 191 | positive regulation of fatty acid transport (GO:2000193) | 2.23029422 |
| 192 | DNA methylation involved in gamete generation (GO:0043046) | 2.22688814 |
| 193 | protein complex biogenesis (GO:0070271) | 2.21928620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.79058329 |
| 2 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.28597562 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.19178584 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.99179176 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.72529919 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.65103669 |
| 7 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.48005030 |
| 8 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.47134207 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.33272573 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.31271029 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.27684925 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.26639267 |
| 13 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.19692949 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.18440410 |
| 15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.15057678 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.11487713 |
| 17 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.10427527 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.03460604 |
| 19 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.02238044 |
| 20 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.99330372 |
| 21 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.99153536 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98111040 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.90518950 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.90185574 |
| 25 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.90173711 |
| 26 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.89735879 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.87917913 |
| 28 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.87804141 |
| 29 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.87320806 |
| 30 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.84522321 |
| 31 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.83428158 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.82313439 |
| 33 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.80828645 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.79160237 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.78127787 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77127307 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75608861 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.75175905 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.74941064 |
| 40 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.74459140 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.71020169 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.68463640 |
| 43 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.68392775 |
| 44 | MYC_22102868_ChIP-Seq_BL_Human | 1.67317381 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.66807304 |
| 46 | P300_19829295_ChIP-Seq_ESCs_Human | 1.66577670 |
| 47 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.65512813 |
| 48 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.62622371 |
| 49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.62552273 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62085928 |
| 51 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.58891131 |
| 52 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.58496750 |
| 53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57456386 |
| 54 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55533208 |
| 55 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.54411912 |
| 56 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.53686379 |
| 57 | EWS_26573619_Chip-Seq_HEK293_Human | 1.52607143 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52230562 |
| 59 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.51247464 |
| 60 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.50982082 |
| 61 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.48219554 |
| 62 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.47659504 |
| 63 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.47619333 |
| 64 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.47278308 |
| 65 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.47278308 |
| 66 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.46609521 |
| 67 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.45112967 |
| 68 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.44220878 |
| 69 | AR_25329375_ChIP-Seq_VCAP_Human | 1.43405382 |
| 70 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.41876997 |
| 71 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.40955250 |
| 72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.40096577 |
| 73 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.39359816 |
| 74 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.38213640 |
| 75 | FUS_26573619_Chip-Seq_HEK293_Human | 1.37316897 |
| 76 | STAT3_23295773_ChIP-Seq_U87_Human | 1.37230165 |
| 77 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.37176765 |
| 78 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.36890778 |
| 79 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.35947280 |
| 80 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.35247729 |
| 81 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.34862913 |
| 82 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.33922923 |
| 83 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.33324017 |
| 84 | AR_20517297_ChIP-Seq_VCAP_Human | 1.33296305 |
| 85 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33231581 |
| 86 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.32734749 |
| 87 | TCF4_23295773_ChIP-Seq_U87_Human | 1.32101428 |
| 88 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.30684628 |
| 89 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.30382973 |
| 90 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29408355 |
| 91 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.29158412 |
| 92 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.28881529 |
| 93 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.28780442 |
| 94 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.26803731 |
| 95 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.26802137 |
| 96 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.26703206 |
| 97 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26530847 |
| 98 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.26062327 |
| 99 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.25934754 |
| 100 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25906423 |
| 101 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.25906423 |
| 102 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.25795416 |
| 103 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.25795416 |
| 104 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.25600400 |
| 105 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.25276630 |
| 106 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.24792307 |
| 107 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.24792307 |
| 108 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.24792307 |
| 109 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.24370362 |
| 110 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.22722239 |
| 111 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22564448 |
| 112 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.22548067 |
| 113 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.22395718 |
| 114 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.22196322 |
| 115 | ATF3_27146783_Chip-Seq_COLON_Human | 1.21404168 |
| 116 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21234283 |
| 117 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.21148532 |
| 118 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.21086656 |
| 119 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.21086656 |
| 120 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.20646394 |
| 121 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20616901 |
| 122 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.20602088 |
| 123 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.19159029 |
| 124 | NCOR_22424771_ChIP-Seq_293T_Human | 1.17392682 |
| 125 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16229023 |
| 126 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15607575 |
| 127 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15101001 |
| 128 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.14890119 |
| 129 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14436547 |
| 130 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14166622 |
| 131 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.13536622 |
| 132 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13162227 |
| 133 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.13052149 |
| 134 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12454554 |
| 135 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.11720021 |
| 136 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.11706480 |
| 137 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.11361755 |
| 138 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.11225255 |
| 139 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11187141 |
| 140 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.10929523 |
| 141 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.10092060 |
| 142 | ERA_21632823_ChIP-Seq_H3396_Human | 1.09992017 |
| 143 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08530974 |
| 144 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08486810 |
| 145 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08424933 |
| 146 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.08164443 |
| 147 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.08086635 |
| 148 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07950565 |
| 149 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.07870891 |
| 150 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07643837 |
| 151 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.07552698 |
| 152 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.06473001 |
| 153 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06349202 |
| 154 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05531147 |
| 155 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05530835 |
| 156 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.05186683 |
| 157 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.04834034 |
| 158 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.04199829 |
| 159 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04018342 |
| 160 | MYB_26560356_Chip-Seq_TH2_Human | 1.03456170 |
| 161 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.03028141 |
| 162 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.02992048 |
| 163 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 1.02918325 |
| 164 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.02673947 |
| 165 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02348237 |
| 166 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.01326084 |
| 167 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01052604 |
| 168 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.01003532 |
| 169 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00600677 |
| 170 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00531944 |
| 171 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.99593809 |
| 172 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.99527052 |
| 173 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.98652454 |
| 174 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98319281 |
| 175 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.98161927 |
| 176 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97816969 |
| 177 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.97647808 |
| 178 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.97601593 |
| 179 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97470880 |
| 180 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96874431 |
| 181 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96717078 |
| 182 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95815541 |
| 183 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.94841882 |
| 184 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94769900 |
| 185 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.94744670 |
| 186 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.94581823 |
| 187 | MYB_26560356_Chip-Seq_TH1_Human | 0.94024476 |
| 188 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93855401 |
| 189 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.93414818 |
| 190 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.93258304 |
| 191 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.93047969 |
| 192 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92509165 |
| 193 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92349205 |
| 194 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92338653 |
| 195 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.92224445 |
| 196 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91786830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004264_abnormal_extraembryonic_tissu | 4.23830739 |
| 2 | MP0002009_preneoplasia | 4.11498383 |
| 3 | MP0001873_stomach_inflammation | 3.92418087 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.82254166 |
| 5 | MP0003195_calcinosis | 3.46502694 |
| 6 | MP0008004_abnormal_stomach_pH | 3.08744704 |
| 7 | MP0005310_abnormal_salivary_gland | 2.84844443 |
| 8 | MP0002166_altered_tumor_susceptibility | 2.62619495 |
| 9 | MP0009278_abnormal_bone_marrow | 2.59591518 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.56247300 |
| 11 | MP0000490_abnormal_crypts_of | 2.54126410 |
| 12 | MP0002653_abnormal_ependyma_morphology | 2.53913805 |
| 13 | MP0008877_abnormal_DNA_methylation | 2.43485929 |
| 14 | MP0002876_abnormal_thyroid_physiology | 2.41052267 |
| 15 | MP0004043_abnormal_pH_regulation | 2.34813776 |
| 16 | MP0005551_abnormal_eye_electrophysiolog | 2.31119767 |
| 17 | MP0003724_increased_susceptibility_to | 2.25516188 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.23473699 |
| 19 | MP0004885_abnormal_endolymph | 2.18114055 |
| 20 | MP0002006_tumorigenesis | 2.12760902 |
| 21 | MP0005397_hematopoietic_system_phenotyp | 2.10560417 |
| 22 | MP0001545_abnormal_hematopoietic_system | 2.10560417 |
| 23 | MP0002102_abnormal_ear_morphology | 2.10461009 |
| 24 | MP0002396_abnormal_hematopoietic_system | 2.10051339 |
| 25 | MP0006054_spinal_hemorrhage | 2.07970404 |
| 26 | MP0003787_abnormal_imprinting | 2.07527183 |
| 27 | MP0000569_abnormal_digit_pigmentation | 2.06858700 |
| 28 | MP0008872_abnormal_physiological_respon | 2.02631275 |
| 29 | MP0003718_maternal_effect | 2.01659234 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.96956150 |
| 31 | MP0009745_abnormal_behavioral_response | 1.96881137 |
| 32 | MP0002638_abnormal_pupillary_reflex | 1.96733599 |
| 33 | MP0002877_abnormal_melanocyte_morpholog | 1.96539671 |
| 34 | MP0000427_abnormal_hair_cycle | 1.96129094 |
| 35 | MP0001501_abnormal_sleep_pattern | 1.94779265 |
| 36 | MP0003866_abnormal_defecation | 1.92754744 |
| 37 | MP0003011_delayed_dark_adaptation | 1.91101329 |
| 38 | MP0002277_abnormal_respiratory_mucosa | 1.90714421 |
| 39 | MP0005085_abnormal_gallbladder_physiolo | 1.88388837 |
| 40 | MP0010368_abnormal_lymphatic_system | 1.88002612 |
| 41 | MP0004133_heterotaxia | 1.85993592 |
| 42 | MP0009046_muscle_twitch | 1.78130551 |
| 43 | MP0005377_hearing/vestibular/ear_phenot | 1.76871242 |
| 44 | MP0003878_abnormal_ear_physiology | 1.76871242 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.75707651 |
| 46 | MP0000613_abnormal_salivary_gland | 1.72542562 |
| 47 | MP0000470_abnormal_stomach_morphology | 1.69515357 |
| 48 | MP0001485_abnormal_pinna_reflex | 1.68327172 |
| 49 | MP0008995_early_reproductive_senescence | 1.63451266 |
| 50 | MP0001666_abnormal_nutrient_absorption | 1.63251860 |
| 51 | MP0000462_abnormal_digestive_system | 1.62091985 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.61659819 |
| 53 | MP0001849_ear_inflammation | 1.59736574 |
| 54 | MP0005174_abnormal_tail_pigmentation | 1.58982445 |
| 55 | MP0002736_abnormal_nociception_after | 1.57917732 |
| 56 | MP0004233_abnormal_muscle_weight | 1.57757385 |
| 57 | MP0002272_abnormal_nervous_system | 1.56058723 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.55571280 |
| 59 | MP0005220_abnormal_exocrine_pancreas | 1.51849919 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 1.50426104 |
| 61 | MP0001663_abnormal_digestive_system | 1.49533287 |
| 62 | MP0004808_abnormal_hematopoietic_stem | 1.46441750 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.45038523 |
| 64 | MP0004142_abnormal_muscle_tone | 1.43595327 |
| 65 | MP0003943_abnormal_hepatobiliary_system | 1.39858837 |
| 66 | MP0002796_impaired_skin_barrier | 1.39639568 |
| 67 | MP0002928_abnormal_bile_duct | 1.38567367 |
| 68 | MP0005381_digestive/alimentary_phenotyp | 1.37877079 |
| 69 | MP0001486_abnormal_startle_reflex | 1.37824519 |
| 70 | MP0002909_abnormal_adrenal_gland | 1.37558594 |
| 71 | MP0005253_abnormal_eye_physiology | 1.37539250 |
| 72 | MP0002249_abnormal_larynx_morphology | 1.35575289 |
| 73 | MP0006276_abnormal_autonomic_nervous | 1.35456963 |
| 74 | MP0000685_abnormal_immune_system | 1.35280172 |
| 75 | MP0002064_seizures | 1.35110422 |
| 76 | MP0002837_dystrophic_cardiac_calcinosis | 1.33025860 |
| 77 | MP0005645_abnormal_hypothalamus_physiol | 1.31905267 |
| 78 | MP0005058_abnormal_lysosome_morphology | 1.31899027 |
| 79 | MP0005171_absent_coat_pigmentation | 1.31559959 |
| 80 | MP0003828_pulmonary_edema | 1.30438028 |
| 81 | MP0003646_muscle_fatigue | 1.29769915 |
| 82 | MP0002733_abnormal_thermal_nociception | 1.28146903 |
| 83 | MP0001881_abnormal_mammary_gland | 1.26445885 |
| 84 | MP0000639_abnormal_adrenal_gland | 1.26060919 |
| 85 | MP0002572_abnormal_emotion/affect_behav | 1.24617789 |
| 86 | MP0005365_abnormal_bile_salt | 1.24617727 |
| 87 | MP0000631_abnormal_neuroendocrine_gland | 1.21928400 |
| 88 | MP0000383_abnormal_hair_follicle | 1.21865254 |
| 89 | MP0000477_abnormal_intestine_morphology | 1.21037038 |
| 90 | MP0001970_abnormal_pain_threshold | 1.20269516 |
| 91 | MP0000681_abnormal_thyroid_gland | 1.20218438 |
| 92 | MP0003172_abnormal_lysosome_physiology | 1.18983858 |
| 93 | MP0001664_abnormal_digestion | 1.18881199 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 1.15598504 |
| 95 | MP0000579_abnormal_nail_morphology | 1.15119454 |
| 96 | MP0005389_reproductive_system_phenotype | 1.14923617 |
| 97 | MP0000230_abnormal_systemic_arterial | 1.14775685 |
| 98 | MP0003136_yellow_coat_color | 1.13201420 |
| 99 | MP0001919_abnormal_reproductive_system | 1.13151302 |
| 100 | MP0004924_abnormal_behavior | 1.12408761 |
| 101 | MP0005386_behavior/neurological_phenoty | 1.12408761 |
| 102 | MP0004742_abnormal_vestibular_system | 1.11932933 |
| 103 | MP0010329_abnormal_lipoprotein_level | 1.11900422 |
| 104 | MP0003763_abnormal_thymus_physiology | 1.11631038 |
| 105 | MP0002735_abnormal_chemical_nociception | 1.11426050 |
| 106 | MP0003045_fibrosis | 1.09297012 |
| 107 | MP0002557_abnormal_social/conspecific_i | 1.06276427 |
| 108 | MP0001765_abnormal_ion_homeostasis | 1.06217682 |
| 109 | MP0009764_decreased_sensitivity_to | 1.02789557 |
| 110 | MP0001905_abnormal_dopamine_level | 1.02674407 |
| 111 | MP0003566_abnormal_cell_adhesion | 1.02570336 |
| 112 | MP0003252_abnormal_bile_duct | 1.01549513 |
| 113 | MP0005165_increased_susceptibility_to | 1.00350885 |
| 114 | MP0004019_abnormal_vitamin_homeostasis | 0.97979801 |
| 115 | MP0000538_abnormal_urinary_bladder | 0.96562188 |
| 116 | MP0010386_abnormal_urinary_bladder | 0.96294175 |
| 117 | MP0003638_abnormal_response/metabolism_ | 0.95234546 |
| 118 | MP0001502_abnormal_circadian_rhythm | 0.95157700 |
| 119 | MP0003880_abnormal_central_pattern | 0.95046257 |
| 120 | MP0001879_abnormal_lymphatic_vessel | 0.94915158 |
| 121 | MP0004145_abnormal_muscle_electrophysio | 0.94151585 |
| 122 | MP0003699_abnormal_female_reproductive | 0.93840953 |
| 123 | MP0003879_abnormal_hair_cell | 0.91350691 |
| 124 | MP0005367_renal/urinary_system_phenotyp | 0.91100230 |
| 125 | MP0000516_abnormal_urinary_system | 0.91100230 |
| 126 | MP0003635_abnormal_synaptic_transmissio | 0.90863948 |
| 127 | MP0002067_abnormal_sensory_capabilities | 0.90168568 |
| 128 | MP0002229_neurodegeneration | 0.89507363 |
| 129 | MP0002160_abnormal_reproductive_system | 0.89215976 |
| 130 | MP0002063_abnormal_learning/memory/cond | 0.88908252 |
| 131 | MP0005636_abnormal_mineral_homeostasis | 0.88669677 |
| 132 | MP0001986_abnormal_taste_sensitivity | 0.88166663 |
| 133 | MP0005448_abnormal_energy_balance | 0.87925605 |
| 134 | MP0005084_abnormal_gallbladder_morpholo | 0.87270694 |
| 135 | MP0002405_respiratory_system_inflammati | 0.86880590 |
| 136 | MP0010352_gastrointestinal_tract_polyps | 0.86839929 |
| 137 | MP0002086_abnormal_extraembryonic_tissu | 0.86630900 |
| 138 | MP0004782_abnormal_surfactant_physiolog | 0.85366642 |
| 139 | MP0005332_abnormal_amino_acid | 0.84826562 |
| 140 | MP0005195_abnormal_posterior_eye | 0.84383323 |
| 141 | MP0001756_abnormal_urination | 0.84109491 |
| 142 | MP0004947_skin_inflammation | 0.83903264 |
| 143 | MP0000465_gastrointestinal_hemorrhage | 0.83576946 |
| 144 | MP0001944_abnormal_pancreas_morphology | 0.83526086 |
| 145 | MP0003119_abnormal_digestive_system | 0.83264624 |
| 146 | MP0006292_abnormal_olfactory_placode | 0.83103441 |
| 147 | MP0000678_abnormal_parathyroid_gland | 0.82786714 |
| 148 | MP0003567_abnormal_fetal_cardiomyocyte | 0.81994307 |
| 149 | MP0005647_abnormal_sex_gland | 0.81391518 |
| 150 | MP0002019_abnormal_tumor_incidence | 0.81043553 |
| 151 | MP0005395_other_phenotype | 0.81023115 |
| 152 | MP0001324_abnormal_eye_pigmentation | 0.80012066 |
| 153 | MP0002060_abnormal_skin_morphology | 0.79901599 |
| 154 | MP0002282_abnormal_trachea_morphology | 0.78755157 |
| 155 | MP0006072_abnormal_retinal_apoptosis | 0.77220216 |
| 156 | MP0001835_abnormal_antigen_presentation | 0.77173872 |
| 157 | MP0001348_abnormal_lacrimal_gland | 0.76712163 |
| 158 | MP0004484_altered_response_of | 0.75799292 |
| 159 | MP0003183_abnormal_peptide_metabolism | 0.74647818 |
| 160 | MP0005646_abnormal_pituitary_gland | 0.74581201 |
| 161 | MP0001845_abnormal_inflammatory_respons | 0.74412731 |
| 162 | MP0002254_reproductive_system_inflammat | 0.73911107 |
| 163 | MP0001764_abnormal_homeostasis | 0.73415225 |
| 164 | MP0002132_abnormal_respiratory_system | 0.73207276 |
| 165 | MP0003122_maternal_imprinting | 0.73005764 |
| 166 | MP0003283_abnormal_digestive_organ | 0.72697291 |
| 167 | MP0001119_abnormal_female_reproductive | 0.72470268 |
| 168 | MP0005671_abnormal_response_to | 0.71811464 |
| 169 | MP0004147_increased_porphyrin_level | 0.70329250 |
| 170 | MP0009780_abnormal_chondrocyte_physiolo | 0.69137319 |
| 171 | MP0004957_abnormal_blastocyst_morpholog | 0.68141303 |
| 172 | MP0002693_abnormal_pancreas_physiology | 0.68024798 |
| 173 | MP0000627_abnormal_mammary_gland | 0.65760345 |
| 174 | MP0002398_abnormal_bone_marrow | 0.64952097 |
| 175 | MP0002098_abnormal_vibrissa_morphology | 0.64248757 |
| 176 | MP0001697_abnormal_embryo_size | 0.63279564 |
| 177 | MP0003941_abnormal_skin_development | 0.62981717 |
| 178 | MP0000343_altered_response_to | 0.62751141 |
| 179 | MP0000689_abnormal_spleen_morphology | 0.62368276 |
| 180 | MP0009785_altered_susceptibility_to | 0.62256445 |
| 181 | MP0003786_premature_aging | 0.61251033 |
| 182 | MP0005501_abnormal_skin_physiology | 0.60971226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pancreatic cysts (HP:0001737) | 4.55633910 |
| 2 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.31975439 |
| 3 | Mucopolysacchariduria (HP:0008155) | 4.31975439 |
| 4 | True hermaphroditism (HP:0010459) | 4.24617123 |
| 5 | Abnormality of midbrain morphology (HP:0002418) | 4.23740120 |
| 6 | Molar tooth sign on MRI (HP:0002419) | 4.23740120 |
| 7 | Pustule (HP:0200039) | 4.19645013 |
| 8 | Male infertility (HP:0003251) | 4.15900200 |
| 9 | Congenital stationary night blindness (HP:0007642) | 4.12781506 |
| 10 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.04666064 |
| 11 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.04666064 |
| 12 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.04666064 |
| 13 | Pancreatic fibrosis (HP:0100732) | 4.00333076 |
| 14 | Annular pancreas (HP:0001734) | 3.99611727 |
| 15 | Lip pit (HP:0100267) | 3.89597586 |
| 16 | Thrombocytosis (HP:0001894) | 3.87493218 |
| 17 | Nephronophthisis (HP:0000090) | 3.55554159 |
| 18 | Dysostosis multiplex (HP:0000943) | 3.52682458 |
| 19 | Abnormality of the renal cortex (HP:0011035) | 3.39117743 |
| 20 | Abnormality of the renal medulla (HP:0100957) | 3.20636048 |
| 21 | Hyperventilation (HP:0002883) | 3.19237079 |
| 22 | Type II lissencephaly (HP:0007260) | 3.14089910 |
| 23 | Decreased circulating renin level (HP:0003351) | 3.06654506 |
| 24 | Poikiloderma (HP:0001029) | 3.05969810 |
| 25 | Right ventricular cardiomyopathy (HP:0011663) | 3.02898900 |
| 26 | Vacuolated lymphocytes (HP:0001922) | 2.96747396 |
| 27 | Attenuation of retinal blood vessels (HP:0007843) | 2.96495770 |
| 28 | Type 2 muscle fiber atrophy (HP:0003554) | 2.96041224 |
| 29 | Abnormal hemoglobin (HP:0011902) | 2.92363557 |
| 30 | Tubular atrophy (HP:0000092) | 2.90564725 |
| 31 | Pili torti (HP:0003777) | 2.90305333 |
| 32 | Milia (HP:0001056) | 2.85349333 |
| 33 | Abolished electroretinogram (ERG) (HP:0000550) | 2.84442132 |
| 34 | Cystic liver disease (HP:0006706) | 2.82831842 |
| 35 | Aplastic anemia (HP:0001915) | 2.82376179 |
| 36 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.82013263 |
| 37 | Alopecia of scalp (HP:0002293) | 2.81530488 |
| 38 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.80205349 |
| 39 | Absent/shortened dynein arms (HP:0200106) | 2.80205349 |
| 40 | Abnormality of male internal genitalia (HP:0000022) | 2.80143644 |
| 41 | Muscle fiber atrophy (HP:0100295) | 2.78785388 |
| 42 | Vertebral hypoplasia (HP:0008417) | 2.75179887 |
| 43 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.75179887 |
| 44 | Abnormal drinking behavior (HP:0030082) | 2.74468526 |
| 45 | Polydipsia (HP:0001959) | 2.74468526 |
| 46 | Inability to walk (HP:0002540) | 2.73811285 |
| 47 | Concave nail (HP:0001598) | 2.71102203 |
| 48 | Decreased central vision (HP:0007663) | 2.71002810 |
| 49 | Growth hormone excess (HP:0000845) | 2.70706448 |
| 50 | Acute myeloid leukemia (HP:0004808) | 2.70173815 |
| 51 | Stomatitis (HP:0010280) | 2.69553472 |
| 52 | Medial flaring of the eyebrow (HP:0010747) | 2.67206339 |
| 53 | Exocrine pancreatic insufficiency (HP:0001738) | 2.65193044 |
| 54 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.63585257 |
| 55 | Abnormality of alanine metabolism (HP:0010916) | 2.63585257 |
| 56 | Hyperalaninemia (HP:0003348) | 2.63585257 |
| 57 | Pendular nystagmus (HP:0012043) | 2.60465861 |
| 58 | Shawl scrotum (HP:0000049) | 2.59032942 |
| 59 | Hypothermia (HP:0002045) | 2.57927956 |
| 60 | Onycholysis (HP:0001806) | 2.57813006 |
| 61 | Congenital, generalized hypertrichosis (HP:0004540) | 2.55888702 |
| 62 | Facial hemangioma (HP:0000329) | 2.55652059 |
| 63 | Chronic hepatic failure (HP:0100626) | 2.55505163 |
| 64 | IgA deficiency (HP:0002720) | 2.51740508 |
| 65 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.50868137 |
| 66 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.50868137 |
| 67 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.47243874 |
| 68 | Nonprogressive disorder (HP:0003680) | 2.47170427 |
| 69 | Furrowed tongue (HP:0000221) | 2.46171610 |
| 70 | Progressive inability to walk (HP:0002505) | 2.44248370 |
| 71 | Easy fatigability (HP:0003388) | 2.43745399 |
| 72 | Fatigue (HP:0012378) | 2.40280969 |
| 73 | Stomach cancer (HP:0012126) | 2.40181287 |
| 74 | Premature skin wrinkling (HP:0100678) | 2.40020931 |
| 75 | Clumsiness (HP:0002312) | 2.38175399 |
| 76 | Genetic anticipation (HP:0003743) | 2.37999373 |
| 77 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.37957828 |
| 78 | Cheilitis (HP:0100825) | 2.35460516 |
| 79 | Hypoplasia of the pons (HP:0012110) | 2.34233648 |
| 80 | Abnormality of the neuromuscular junction (HP:0003398) | 2.30662264 |
| 81 | Fatigable weakness (HP:0003473) | 2.30662264 |
| 82 | Tongue fasciculations (HP:0001308) | 2.29966628 |
| 83 | Progressive neurologic deterioration (HP:0002344) | 2.29868575 |
| 84 | Male pseudohermaphroditism (HP:0000037) | 2.29095406 |
| 85 | Abnormality of the fingertips (HP:0001211) | 2.28769534 |
| 86 | Gaze-evoked nystagmus (HP:0000640) | 2.27299866 |
| 87 | Abnormality of renin-angiotensin system (HP:0000847) | 2.26136103 |
| 88 | Progressive cerebellar ataxia (HP:0002073) | 2.26007301 |
| 89 | Polycythemia (HP:0001901) | 2.25495182 |
| 90 | Sclerocornea (HP:0000647) | 2.25260486 |
| 91 | Increased corneal curvature (HP:0100692) | 2.23266870 |
| 92 | Keratoconus (HP:0000563) | 2.23266870 |
| 93 | Hypoplasia of the uterus (HP:0000013) | 2.22249758 |
| 94 | Large for gestational age (HP:0001520) | 2.21938009 |
| 95 | Abnormality of the nasal mucosa (HP:0000433) | 2.21721122 |
| 96 | Joint stiffness (HP:0001387) | 2.19222408 |
| 97 | Hypoplasia of the ulna (HP:0003022) | 2.18245996 |
| 98 | Congenital hip dislocation (HP:0001374) | 2.17339549 |
| 99 | Abnormal number of erythroid precursors (HP:0012131) | 2.17334016 |
| 100 | Capillary hemangiomas (HP:0005306) | 2.16507761 |
| 101 | Reduced antithrombin III activity (HP:0001976) | 2.16406915 |
| 102 | Intestinal atresia (HP:0011100) | 2.16388016 |
| 103 | Albinism (HP:0001022) | 2.15981637 |
| 104 | Type I transferrin isoform profile (HP:0003642) | 2.15637623 |
| 105 | Ketosis (HP:0001946) | 2.13843994 |
| 106 | Muscle fibrillation (HP:0010546) | 2.13713416 |
| 107 | Ketoacidosis (HP:0001993) | 2.13585966 |
| 108 | Amelogenesis imperfecta (HP:0000705) | 2.13167275 |
| 109 | Renal cortical cysts (HP:0000803) | 2.12486320 |
| 110 | Bile duct proliferation (HP:0001408) | 2.12427192 |
| 111 | Abnormal biliary tract physiology (HP:0012439) | 2.12427192 |
| 112 | Abnormality of cochlea (HP:0000375) | 2.12361051 |
| 113 | Polyuria (HP:0000103) | 2.12322805 |
| 114 | Congenital sensorineural hearing impairment (HP:0008527) | 2.11967716 |
| 115 | Short humerus (HP:0005792) | 2.11814364 |
| 116 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.11067657 |
| 117 | Congenital hepatic fibrosis (HP:0002612) | 2.11003775 |
| 118 | Abnormality of the gastric mucosa (HP:0004295) | 2.10516342 |
| 119 | Abnormal ciliary motility (HP:0012262) | 2.09876749 |
| 120 | Gait imbalance (HP:0002141) | 2.07473963 |
| 121 | Agitation (HP:0000713) | 2.06935496 |
| 122 | Hypergonadotropic hypogonadism (HP:0000815) | 2.06520146 |
| 123 | Lissencephaly (HP:0001339) | 2.06392697 |
| 124 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.05953943 |
| 125 | Short chin (HP:0000331) | 2.03727476 |
| 126 | Broad-based gait (HP:0002136) | 2.03672019 |
| 127 | Severe muscular hypotonia (HP:0006829) | 2.03141162 |
| 128 | Intestinal fistula (HP:0100819) | 2.02682289 |
| 129 | Interstitial pulmonary disease (HP:0006530) | 2.01783037 |
| 130 | Plantar hyperkeratosis (HP:0007556) | 1.99821086 |
| 131 | Abnormal albumin level (HP:0012116) | 1.99724399 |
| 132 | Hypoalbuminemia (HP:0003073) | 1.99724399 |
| 133 | Hypokinesia (HP:0002375) | 1.97330297 |
| 134 | Beaking of vertebral bodies (HP:0004568) | 1.95870671 |
| 135 | Ureteral stenosis (HP:0000071) | 1.95832350 |
| 136 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.95799017 |
| 137 | Bowing of the arm (HP:0006488) | 1.95670858 |
| 138 | Bowed forearm bones (HP:0003956) | 1.95670858 |
| 139 | Congenital primary aphakia (HP:0007707) | 1.95469678 |
| 140 | Asymmetric septal hypertrophy (HP:0001670) | 1.94819953 |
| 141 | Retrobulbar optic neuritis (HP:0100654) | 1.94818527 |
| 142 | Optic neuritis (HP:0100653) | 1.94818527 |
| 143 | Myositis (HP:0100614) | 1.94226291 |
| 144 | Abnormality of the pons (HP:0007361) | 1.94087651 |
| 145 | Hypomagnesemia (HP:0002917) | 1.92812408 |
| 146 | Anencephaly (HP:0002323) | 1.92721303 |
| 147 | Volvulus (HP:0002580) | 1.92481110 |
| 148 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.92326296 |
| 149 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.92012380 |
| 150 | Oligodontia (HP:0000677) | 1.92004341 |
| 151 | Occipital encephalocele (HP:0002085) | 1.91993417 |
| 152 | Pigmentary retinal degeneration (HP:0001146) | 1.90188674 |
| 153 | Hypotrichosis (HP:0001006) | 1.89990159 |
| 154 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.89563615 |
| 155 | Vaginal fistula (HP:0004320) | 1.88848708 |
| 156 | 3-Methylglutaconic aciduria (HP:0003535) | 1.88275355 |
| 157 | Adactyly (HP:0009776) | 1.88271158 |
| 158 | Hyperparathyroidism (HP:0000843) | 1.88005181 |
| 159 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.87914592 |
| 160 | Chorioretinal atrophy (HP:0000533) | 1.87695033 |
| 161 | Papillary thyroid carcinoma (HP:0002895) | 1.87080745 |
| 162 | Orchitis (HP:0100796) | 1.86884945 |
| 163 | Progressive muscle weakness (HP:0003323) | 1.86423801 |
| 164 | Increased IgM level (HP:0003496) | 1.84762352 |
| 165 | Nasal polyposis (HP:0100582) | 1.84496989 |
| 166 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.84396916 |
| 167 | Ureteral obstruction (HP:0006000) | 1.83734260 |
| 168 | Hemiparesis (HP:0001269) | 1.83427585 |
| 169 | Infertility (HP:0000789) | 1.80900928 |
| 170 | Colitis (HP:0002583) | 1.80752541 |
| 171 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 1.80070136 |
| 172 | Tachypnea (HP:0002789) | 1.79948660 |
| 173 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.79530451 |
| 174 | Nephrogenic diabetes insipidus (HP:0009806) | 1.79517247 |
| 175 | Rectal fistula (HP:0100590) | 1.78374314 |
| 176 | Rectovaginal fistula (HP:0000143) | 1.78374314 |
| 177 | Absent speech (HP:0001344) | 1.78148539 |
| 178 | Abnormality of the intrinsic pathway (HP:0010989) | 1.78087938 |
| 179 | Febrile seizures (HP:0002373) | 1.77738662 |
| 180 | Fair hair (HP:0002286) | 1.77298666 |
| 181 | Abnormality of T cell physiology (HP:0011840) | 1.77165103 |
| 182 | Abnormality of renal excretion (HP:0011036) | 1.76830272 |
| 183 | Bifid uvula (HP:0000193) | 1.76153351 |
| 184 | Protruding tongue (HP:0010808) | 1.75753015 |
| 185 | Coarse hair (HP:0002208) | 1.74581907 |
| 186 | Mesangial abnormality (HP:0001966) | 1.74171690 |
| 187 | Progressive hearing impairment (HP:0001730) | 1.74027426 |
| 188 | Sparse lateral eyebrow (HP:0005338) | 1.73529923 |
| 189 | Rib fusion (HP:0000902) | 1.72783044 |
| 190 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.71905916 |
| 191 | Postaxial foot polydactyly (HP:0001830) | 1.71069211 |
| 192 | Metabolic alkalosis (HP:0200114) | 1.70819725 |
| 193 | Abnormal urine output (HP:0012590) | 1.69142450 |
| 194 | Macular degeneration (HP:0000608) | 1.68425849 |
| 195 | Generalized hypopigmentation of hair (HP:0011358) | 1.66268592 |
| 196 | Hyperaldosteronism (HP:0000859) | 1.66236701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K6 | 4.18311798 |
| 2 | AKT3 | 3.68134353 |
| 3 | MAPK15 | 3.67477621 |
| 4 | MATK | 3.60091934 |
| 5 | ADRBK2 | 3.42886935 |
| 6 | BMPR1B | 3.31370680 |
| 7 | TAOK3 | 3.18859178 |
| 8 | LATS1 | 2.83618956 |
| 9 | GRK1 | 2.66832169 |
| 10 | WNK4 | 2.62828618 |
| 11 | DAPK2 | 2.40028662 |
| 12 | TRPM7 | 2.35312526 |
| 13 | EEF2K | 2.35002462 |
| 14 | MAPKAPK3 | 2.32160864 |
| 15 | PINK1 | 2.20649350 |
| 16 | OXSR1 | 2.18081671 |
| 17 | TLK1 | 2.16116442 |
| 18 | DAPK1 | 2.15448455 |
| 19 | MAP3K11 | 2.07930537 |
| 20 | WNK3 | 2.02553669 |
| 21 | DDR2 | 2.01613952 |
| 22 | TIE1 | 1.91362624 |
| 23 | ICK | 1.78611830 |
| 24 | TAOK1 | 1.76474302 |
| 25 | ERN1 | 1.74889305 |
| 26 | MUSK | 1.71126220 |
| 27 | MST4 | 1.69890269 |
| 28 | ZAK | 1.69564437 |
| 29 | CASK | 1.69429484 |
| 30 | MAP4K2 | 1.67051501 |
| 31 | MAPK13 | 1.62762360 |
| 32 | TNK2 | 1.62226478 |
| 33 | TXK | 1.59509633 |
| 34 | MAP3K12 | 1.58285304 |
| 35 | STK39 | 1.56642380 |
| 36 | RPS6KB2 | 1.54975388 |
| 37 | EPHA2 | 1.47852876 |
| 38 | CDK19 | 1.45467137 |
| 39 | ADRBK1 | 1.44965945 |
| 40 | MYLK | 1.42662832 |
| 41 | SIK1 | 1.35963346 |
| 42 | PAK3 | 1.35867459 |
| 43 | PRKD2 | 1.34636112 |
| 44 | IRAK1 | 1.34592094 |
| 45 | CAMKK2 | 1.33149746 |
| 46 | FLT3 | 1.32560873 |
| 47 | FRK | 1.29070335 |
| 48 | PTK2B | 1.27445259 |
| 49 | HIPK2 | 1.25541309 |
| 50 | LATS2 | 1.24804396 |
| 51 | RIPK1 | 1.20109876 |
| 52 | CDK8 | 1.18499187 |
| 53 | DYRK1B | 1.15004506 |
| 54 | TGFBR2 | 1.05585013 |
| 55 | PRKCE | 1.02381136 |
| 56 | RAF1 | 1.01720056 |
| 57 | TYRO3 | 0.96841510 |
| 58 | LMTK2 | 0.96461969 |
| 59 | BCKDK | 0.95447626 |
| 60 | DMPK | 0.94840265 |
| 61 | CSK | 0.94075087 |
| 62 | CDK6 | 0.93894559 |
| 63 | PRKAA2 | 0.93748219 |
| 64 | IRAK4 | 0.93674047 |
| 65 | FGR | 0.93435993 |
| 66 | KIT | 0.90613761 |
| 67 | PIM2 | 0.89834097 |
| 68 | PHKG1 | 0.89588474 |
| 69 | PHKG2 | 0.89588474 |
| 70 | BMX | 0.88795081 |
| 71 | STK38L | 0.88684799 |
| 72 | NTRK3 | 0.85099166 |
| 73 | PRKG2 | 0.82878795 |
| 74 | MAPKAPK5 | 0.82580659 |
| 75 | CHUK | 0.79985371 |
| 76 | STK3 | 0.78653098 |
| 77 | YES1 | 0.78387249 |
| 78 | PIM1 | 0.76476392 |
| 79 | EPHB1 | 0.75358793 |
| 80 | MAP3K4 | 0.75061914 |
| 81 | PRKCG | 0.74529195 |
| 82 | DYRK2 | 0.73814005 |
| 83 | JAK3 | 0.73337717 |
| 84 | NUAK1 | 0.73243622 |
| 85 | STK10 | 0.69825888 |
| 86 | FES | 0.68292648 |
| 87 | IKBKE | 0.67473476 |
| 88 | CDK7 | 0.66895263 |
| 89 | MAP3K9 | 0.66882040 |
| 90 | TGFBR1 | 0.66751033 |
| 91 | IKBKB | 0.66304939 |
| 92 | PIK3CA | 0.65984608 |
| 93 | PRKCI | 0.65590694 |
| 94 | GRK6 | 0.63737369 |
| 95 | KSR2 | 0.63590804 |
| 96 | MAP2K3 | 0.63470716 |
| 97 | MAPK11 | 0.63420218 |
| 98 | MAP4K1 | 0.63192613 |
| 99 | STK11 | 0.63072134 |
| 100 | KDR | 0.62478095 |
| 101 | PDGFRA | 0.62079955 |
| 102 | INSRR | 0.62013722 |
| 103 | STK24 | 0.61824591 |
| 104 | TEC | 0.61512058 |
| 105 | NLK | 0.59102943 |
| 106 | ITK | 0.58704805 |
| 107 | PNCK | 0.58619881 |
| 108 | PRKCZ | 0.58313700 |
| 109 | PRKCQ | 0.57952853 |
| 110 | CSNK1G2 | 0.56414244 |
| 111 | PIK3CG | 0.55689583 |
| 112 | ERBB4 | 0.55515623 |
| 113 | PRKAA1 | 0.55282985 |
| 114 | STK38 | 0.54798463 |
| 115 | CAMK1 | 0.54507143 |
| 116 | FER | 0.52923128 |
| 117 | CAMKK1 | 0.52416319 |
| 118 | CSNK1G1 | 0.51970764 |
| 119 | EPHA3 | 0.51580005 |
| 120 | JAK2 | 0.51054788 |
| 121 | RPS6KL1 | 0.50308728 |
| 122 | RPS6KC1 | 0.50308728 |
| 123 | PAK4 | 0.50265935 |
| 124 | BRSK2 | 0.48458227 |
| 125 | BTK | 0.48223583 |
| 126 | ZAP70 | 0.47522314 |
| 127 | CSNK1G3 | 0.47518384 |
| 128 | CAMK1D | 0.47262416 |
| 129 | MARK1 | 0.46629784 |
| 130 | RPS6KA6 | 0.46071651 |
| 131 | FGFR2 | 0.45605463 |
| 132 | MAP2K7 | 0.43647296 |
| 133 | CAMK2A | 0.43102592 |
| 134 | SIK2 | 0.42828290 |
| 135 | RPS6KB1 | 0.41694539 |
| 136 | RPS6KA1 | 0.41281240 |
| 137 | PRKACA | 0.41213357 |
| 138 | RIPK4 | 0.41055914 |
| 139 | LRRK2 | 0.40994952 |
| 140 | MAP2K1 | 0.40532191 |
| 141 | MAP3K1 | 0.40055669 |
| 142 | PKN2 | 0.39849361 |
| 143 | RPS6KA5 | 0.39767983 |
| 144 | LYN | 0.38773691 |
| 145 | PTK2 | 0.38534319 |
| 146 | EPHA4 | 0.38086431 |
| 147 | CDC42BPA | 0.37774340 |
| 148 | WNK1 | 0.36760726 |
| 149 | CSNK1A1 | 0.36499102 |
| 150 | MAP2K4 | 0.36345628 |
| 151 | PDK1 | 0.35496190 |
| 152 | PRKCA | 0.35181778 |
| 153 | GRK5 | 0.34836247 |
| 154 | SCYL2 | 0.34620517 |
| 155 | CDK9 | 0.34321724 |
| 156 | CCNB1 | 0.34041505 |
| 157 | BLK | 0.32843290 |
| 158 | ACVR1B | 0.32689258 |
| 159 | SGK2 | 0.31535218 |
| 160 | JAK1 | 0.31319908 |
| 161 | MAP2K2 | 0.31232180 |
| 162 | ERBB2 | 0.31133080 |
| 163 | MAPK3 | 0.31063503 |
| 164 | SYK | 0.31043005 |
| 165 | NME1 | 0.30875949 |
| 166 | MAP2K6 | 0.30714734 |
| 167 | TNIK | 0.29854354 |
| 168 | MAP3K13 | 0.29712199 |
| 169 | CSNK1A1L | 0.29097531 |
| 170 | NTRK2 | 0.28981835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.95922581 |
| 2 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.74446955 |
| 3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.01731093 |
| 4 | Circadian rhythm_Homo sapiens_hsa04710 | 2.95377851 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.76879223 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 2.60381843 |
| 7 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.35024839 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.24927391 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16929795 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.16238815 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.12860121 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 2.09354326 |
| 13 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.01832101 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.99508190 |
| 15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.94772202 |
| 16 | Adherens junction_Homo sapiens_hsa04520 | 1.92213826 |
| 17 | Thyroid cancer_Homo sapiens_hsa05216 | 1.90817293 |
| 18 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.87032037 |
| 19 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.85452643 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.82644552 |
| 21 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.80748685 |
| 22 | Nicotine addiction_Homo sapiens_hsa05033 | 1.73634739 |
| 23 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.67066861 |
| 24 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.62173251 |
| 25 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.60452755 |
| 26 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.54650569 |
| 27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.54190631 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.52032453 |
| 29 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.45363948 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.44701625 |
| 31 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.37205347 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.36499648 |
| 33 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.36358044 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.36324305 |
| 35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.35621421 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.33801622 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.29526118 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.29384325 |
| 39 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.28924624 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 1.28263670 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.25981890 |
| 42 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.23310173 |
| 43 | Taste transduction_Homo sapiens_hsa04742 | 1.22951480 |
| 44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.21070085 |
| 45 | Olfactory transduction_Homo sapiens_hsa04740 | 1.20995788 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.20880904 |
| 47 | Mismatch repair_Homo sapiens_hsa03430 | 1.20469821 |
| 48 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.20089986 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.19655550 |
| 50 | Insulin secretion_Homo sapiens_hsa04911 | 1.19136792 |
| 51 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.17771543 |
| 52 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.16466614 |
| 53 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.15204714 |
| 54 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.14876141 |
| 55 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.14256648 |
| 56 | Bladder cancer_Homo sapiens_hsa05219 | 1.12638377 |
| 57 | Shigellosis_Homo sapiens_hsa05131 | 1.12277572 |
| 58 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.11303876 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 1.08684063 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.07524770 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06305510 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.05568262 |
| 63 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.04942879 |
| 64 | DNA replication_Homo sapiens_hsa03030 | 1.04287539 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.03411038 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01640023 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01119518 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.00353650 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.99833827 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.99518873 |
| 71 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.97262143 |
| 72 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.96898744 |
| 73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.96763163 |
| 74 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.96059220 |
| 75 | Protein export_Homo sapiens_hsa03060 | 0.94707417 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.94480456 |
| 77 | Circadian entrainment_Homo sapiens_hsa04713 | 0.94162153 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93615183 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.91443723 |
| 80 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.89639552 |
| 81 | Parkinsons disease_Homo sapiens_hsa05012 | 0.88373902 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.87699540 |
| 83 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.86304974 |
| 84 | GABAergic synapse_Homo sapiens_hsa04727 | 0.85965676 |
| 85 | Tight junction_Homo sapiens_hsa04530 | 0.84826635 |
| 86 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.83087365 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80364908 |
| 88 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.78548146 |
| 89 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78150837 |
| 90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.78068159 |
| 91 | Salivary secretion_Homo sapiens_hsa04970 | 0.78018056 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77175811 |
| 93 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.76678456 |
| 94 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.73441204 |
| 95 | RNA degradation_Homo sapiens_hsa03018 | 0.72812224 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.72766689 |
| 97 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.72741700 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.72238784 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.71989049 |
| 100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71725247 |
| 101 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70872950 |
| 102 | Cell cycle_Homo sapiens_hsa04110 | 0.69414465 |
| 103 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68997176 |
| 104 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.68123379 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | 0.67945363 |
| 106 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.66792382 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66479459 |
| 108 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66136728 |
| 109 | Hepatitis B_Homo sapiens_hsa05161 | 0.65830035 |
| 110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64367391 |
| 111 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.64021375 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63898976 |
| 113 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.63254139 |
| 114 | Sulfur relay system_Homo sapiens_hsa04122 | 0.63107329 |
| 115 | Lysosome_Homo sapiens_hsa04142 | 0.62590854 |
| 116 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62343398 |
| 117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61600945 |
| 118 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.61247327 |
| 119 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60524611 |
| 120 | Huntingtons disease_Homo sapiens_hsa05016 | 0.60324721 |
| 121 | Alzheimers disease_Homo sapiens_hsa05010 | 0.60308704 |
| 122 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.60186731 |
| 123 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59200017 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58811422 |
| 125 | RNA polymerase_Homo sapiens_hsa03020 | 0.57897156 |
| 126 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57346362 |
| 127 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.56734097 |
| 128 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.56648129 |
| 129 | Homologous recombination_Homo sapiens_hsa03440 | 0.56266455 |
| 130 | Cocaine addiction_Homo sapiens_hsa05030 | 0.55450375 |
| 131 | Measles_Homo sapiens_hsa05162 | 0.55438311 |
| 132 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.55151076 |
| 133 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54641327 |
| 134 | Influenza A_Homo sapiens_hsa05164 | 0.54586202 |
| 135 | Focal adhesion_Homo sapiens_hsa04510 | 0.54423695 |
| 136 | Asthma_Homo sapiens_hsa05310 | 0.53480508 |
| 137 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.52316887 |
| 138 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.52086213 |
| 139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51642254 |
| 140 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51506697 |
| 141 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.50690040 |
| 142 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48752437 |
| 143 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48600257 |
| 144 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.48179321 |
| 145 | Long-term depression_Homo sapiens_hsa04730 | 0.48011710 |
| 146 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.47923760 |
| 147 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47158067 |
| 148 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47107431 |
| 149 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46653435 |
| 150 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46313144 |
| 151 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45423127 |
| 152 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.45289330 |
| 153 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.44127265 |
| 154 | Pathways in cancer_Homo sapiens_hsa05200 | 0.43023698 |
| 155 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42730909 |
| 156 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.41967305 |
| 157 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41599979 |
| 158 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.41585887 |
| 159 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.41437827 |
| 160 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40911973 |
| 161 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.39639011 |
| 162 | Bile secretion_Homo sapiens_hsa04976 | 0.38570178 |
| 163 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38093454 |
| 164 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.37962598 |
| 165 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37644374 |
| 166 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.37118846 |
| 167 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36921171 |
| 168 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36686527 |
| 169 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.35923405 |
| 170 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.35881396 |
| 171 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35288906 |
| 172 | Basal transcription factors_Homo sapiens_hsa03022 | 0.35230464 |
| 173 | Allograft rejection_Homo sapiens_hsa05330 | 0.34914496 |
| 174 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33455799 |
| 175 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31509518 |
| 176 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30945960 |
| 177 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30917590 |
| 178 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.29768887 |

